ACAD8

Across TCGA pan-cancer cohorts, ACAD8 Mutation is linked to patient survival in 8 of 34 cancer types, making it a survival-associated ACAD8 data layer compared with 23 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher ACAD8 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ACAD8 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC, UCEC, and KIRP are the cancer types where ACAD8 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.118	0.768	<.001	24	view →
UCEC	DFS	Median	All	0.970	0.615	.005	20	view →
KIRP	OS	Median	All	0.178	0.885	<.001	18	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
LUSC	OS	Median	II,III,IV	0.133	0.732	<.001	12	view →
COAD	OS	Median	All	0.172	0.870	<.001	12	view →
GBM	OS	Median	All	0.089	0.413	.023	6	view →
LIHC	OS	Median	All	0.471	0.785	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

ACAD8–HNSC (OS)

Open the HNSC breakdown →